NVAX   $10.0  -1.09% Market Closed After Close 10.01 0.10%

Novavax Inc
Total Cash 1.05B
totalCashPerShare 6.556
EBITDA -240.84M
Total Debt 263.54M
quickRatio 0.934
currentRatio 1.039
Total Revenue 987.67M
debtToEquity
Revenue/Share 7.659
ROA -0.10212
ROE
grossProfits
freeCashflow -97.84M
operatingCashflow 14.28M
earningsGrowth 0.71
revenueGrowth -0.021
grossMargins 0.16174999
ebitdaMargins -0.24385001
operatingMargins 0.39014
profitMargins -0.29801
enterpriseValue 843.70M
forwardPE -63.375004
floatShares 143.30M
sharesOutstanding 160.09M
sharesShort 33.88M
sharesShortPriorMonth 31.61M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.54%
Short Ratio help_outline 5.19%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue -2.7
Price To Book help_outline
earningsQuarterlyGrowth 1.80
netIncomeToCommon -294.33M
trailingEps -2.62%
forwardEps -0.16%
enterpriseToEbitda -3.50
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.83 3Q 2024
institutionsCount 304
lastUpdated Oct. 22, 2024, 3:29 a.m.